Brief: Tianjin Development Posts 9-Mth Net Profit Attributable RMB169.3 Mln For Tianjin Lisheng Pharmaceutical
Oct 30 (Reuters) - Tianjin Lisheng Pharmaceutical Co Ltd
002393.SZ :
* 9-MONTH NET PROFIT ATTRIBUTABLE RMB169.3 MILLION FOR
TIANJIN
LISHENG PHARMACEUTICAL
* 9-MNTH TOTAL OPERATING INCOME RMB1.02 BILLION FOR TIANJIN
LISHENG PHARMACEUTICAL
Further company coverage: 002393.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln